{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "SYN",
    "data": {
        "bs": [
            {
                "label": "Right of use asset",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1468000
            },
            {
                "label": "Total Stockholders' Equity (Deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 73731000
            },
            {
                "label": "Total Stockholders' Equity (Deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 73731000
            },
            {
                "label": "Accrued employee benefits",
                "concept": "AccruedEmployeeBenefitsCurrent",
                "unit": "usd",
                "value": 540000
            },
            {
                "label": "Total Liabilities and Stockholders' Equity (Deficit)",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 77255000
            },
            {
                "label": "Total Liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 3524000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Deposits and other assets",
                "concept": "syn:DepositsAndOtherAssetsNoncurrent",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -262748000
            },
            {
                "label": "Lease liability - long term",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1426000
            },
            {
                "label": "Lease liability - long term",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1426000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 74291000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 74291000
            },
            {
                "label": "Total Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 77255000
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 196000
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 196000
            },
            {
                "label": "Series B convertible preferred stock, $1,000 par value; 10,000,000 shares authorized, 0 issued and outstanding and 3,973 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 568000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 339121000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 794000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 794000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1341000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1341000
            },
            {
                "label": "Non-controlling interest",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -2774000
            },
            {
                "label": "Total Synthetic Biologics, Inc. and Subsidiaries Equity (Deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 76505000
            },
            {
                "label": "Total Current Liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 2098000
            },
            {
                "label": "Series A convertible preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 and 120,000 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively",
                "concept": "TemporaryEquityCarryingAmountAttributableToParent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value; 200,000,000 shares authorized, 132,044,866 issued and 132,042,538 outstanding at June 30, 2021 and 29,252,253 issued and 29,249,925 outstanding at December 31, 2020",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Total Current Assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 75632000
            }
        ],
        "cf": [
            {
                "label": "Operating Lease liability",
                "concept": "syn:IncreaseDecreaseInOperatingLeaseLiability",
                "unit": "usd",
                "value": -121000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 203000
            },
            {
                "label": "Net Cash Provided by Financing Activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 74002000
            },
            {
                "label": "Accrued employee benefits",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -328000
            },
            {
                "label": "Right of use asset",
                "concept": "syn:IncreaseDecreaseRightOfUseAssets",
                "unit": "usd",
                "value": 81000
            },
            {
                "label": "In-kind dividends paid in preferred stock",
                "concept": "DividendsPreferredStockPaidinkind",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 14000
            },
            {
                "label": "Net Cash Used in Investing Activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -14000
            },
            {
                "label": "Net Cash Used in Operating Activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -5924000
            },
            {
                "label": "Conversion of Series B Preferred Stock",
                "concept": "ConversionOfStockAmountConverted1",
                "unit": "usd",
                "value": 2477000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": -131000
            },
            {
                "label": "Depreciation",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 56000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -366000
            },
            {
                "label": "Proceeds from \"at the market\" stock issuance",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 65960000
            },
            {
                "label": "Proceeds from \"at the market\" stock issuance",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 66000000.0
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": 68064000
            },
            {
                "label": "Subsidiary stock issuances to vendor",
                "concept": "syn:SubsidiaryStockIssuesToVendor",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of common stock for warrant exercises",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 8042000
            },
            {
                "label": "Proceeds from issuance of common stock for warrant exercises",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 8000000.0
            },
            {
                "label": "Right of use asset from operating lease",
                "concept": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "unit": "usd",
                "value": 1270000
            },
            {
                "label": "Right of use asset from operating lease",
                "concept": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "unit": "usd",
                "value": 1300000.0
            },
            {
                "label": "Effect of Series A Preferred Stock price adjustment",
                "concept": "syn:PreferredStockPriceAdjustment",
                "unit": "usd",
                "value": 7402000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -318000
            },
            {
                "label": "Deemed dividends for accretion of Series B Preferred Stock discount",
                "concept": "syn:DeemedDividendsWithBeneficialConversionFeature",
                "unit": "usd",
                "value": 1497000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -5732000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -5732000
            }
        ],
        "ic": [
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2685000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 3049000
            },
            {
                "label": "Net Loss Attributable to Synthetic Biologics, Inc. and Subsidiaries",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -5731000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Net Loss Attributable to Non-controlling Interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Net Loss Attributable to Common Stockholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -14654000
            },
            {
                "label": "Net Loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -5732000
            },
            {
                "label": "Net Loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -5732000
            },
            {
                "label": "Total Operating Costs and Expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 5734000
            },
            {
                "label": "Weighted average number of shares outstanding during the period - Basic and Dilutive",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 111539024
            },
            {
                "label": "Total Other Income",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Effect of Series A Preferred Stock Price adjustment",
                "concept": "syn:PreferredStockPriceAdjustment",
                "unit": "usd",
                "value": 7402000
            },
            {
                "label": "Net Loss Per Share - Basic and Dilutive",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.13
            },
            {
                "label": "Loss from Operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -5734000
            }
        ]
    }
}